Clarus Therapeutics Cut to Hold From Buy by Needham
Dow JonesAug 23, 2022 05:12 ET
Clarus Therapeutics Hldgs Analyst Ratings
Benzinga Analyst RatingsAug 23, 2022 05:04 ET
Clarus Therapeutics Holdings (CRXT) Was Downgraded to a Hold Rating at Needham
TipRanksAug 22, 2022 12:10 ET
Clarus Therapeutics Cut to Hold From Buy by Maxim Group
Dow JonesAug 22, 2022 08:14 ET
Clarus Therapeutics Hldgs Analyst Ratings
Benzinga Analyst RatingsAug 22, 2022 08:06 ET
No Data
No Data